Dolutegravir dosing with rifampicin – Authors' reply. Maartens, G. & Griesel, R. The Lancet HIV, Elsevier, sep, 2023.
Dolutegravir dosing with rifampicin – Authors' reply [link]Paper  doi  bibtex   
@article{Maartens2023,
author = {Maartens, Gary and Griesel, Rulan},
doi = {10.1016/S2352-3018(23)00230-8},
file = {:C$\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Maartens, Griesel - 2023 - Dolutegravir dosing with rifampicin – Authors' reply.pdf:pdf},
issn = {2352-3018},
journal = {The Lancet HIV},
keywords = {fund{\_}not{\_}ack,letter},
mendeley-tags = {fund{\_}not{\_}ack,letter},
month = {sep},
pages = {10.1016/ S2352--3018(23)00230--8 1},
pmid = {37717590},
publisher = {Elsevier},
title = {{Dolutegravir dosing with rifampicin – Authors' reply}},
url = {http://www.thelancet.com/article/S2352301823002308/fulltext http://www.thelancet.com/article/S2352301823002308/abstract https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00230-8/abstract},
year = {2023}
}

Downloads: 0